Northern Trust Corp Emergent Bio Solutions Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Northern Trust Corp holds 142,197 shares of EBS stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

142,197

Previous 431,220 67.02%

Holding current value

$1.26 Million

Previous $2.94 Million 59.63%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$5.72 - $14.77 $1.65 Million - $4.27 Million	-289,023 Reduced 67.02%	142,197 $1.19 Million
Q2 2024 Aug 14, 2024	SELL	$1.86 - $6.98 $30,466 - $114,332	-16,380 Reduced 3.66%	431,220 $2.94 Million
Q1 2024 May 14, 2024	SELL	$1.5 - $3.41 $5,823 - $13,237	-3,882 Reduced 0.86%	447,600 $1.13 Million
Q4 2023 Feb 13, 2024	SELL	$1.82 - $3.16 $67,105 - $116,512	-36,871 Reduced 7.55%	451,482 $1.08 Million
Q3 2023 Nov 13, 2023	SELL	$3.17 - $7.91 $141,832 - $353,909	-44,742 Reduced 8.39%	488,353 $1.66 Million
Q2 2023 Aug 11, 2023	SELL	$7.35 - $13.21 $16,184 - $29,088	-2,202 Reduced 0.41%	533,095 $3.92 Million
Q1 2023 May 15, 2023	SELL	$7.79 - $16.29 $2.32 Million - $4.85 Million	-297,565 Reduced 35.73%	535,297 $5.55 Million
Q4 2022 Feb 13, 2023	SELL	$11.0 - $21.45 $101,948 - $198,798	-9,268 Reduced 1.1%	832,862 $9.84 Million
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $4.86 Million - $8.66 Million	241,812 Added 40.28%	842,130 $17.7 Million
Q2 2022 Aug 12, 2022	SELL	$27.42 - $43.63 $430,877 - $685,601	-15,714 Reduced 2.55%	600,318 $18.6 Million
Q1 2022 May 13, 2022	BUY	$36.48 - $52.22 $2.16 Million - $3.09 Million	59,261 Added 10.64%	616,032 $25.3 Million
Q4 2021 Feb 08, 2022	SELL	$33.11 - $55.01 $12.1 Million - $20 Million	-363,963 Reduced 39.53%	556,771 $24.2 Million
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $1 Million - $1.32 Million	-19,999 Reduced 2.13%	920,734 $46.1 Million
Q2 2021 Aug 13, 2021	BUY	$56.61 - $80.46 $9.53 Million - $13.5 Million	168,302 Added 21.79%	940,733 $59.3 Million
Q1 2021 May 12, 2021	SELL	$86.23 - $125.19 $2.66 Million - $3.87 Million	-30,905 Reduced 3.85%	772,431 $71.8 Million
Q4 2020 Feb 11, 2021	BUY	$79.17 - $111.47 $367,348 - $517,220	4,640 Added 0.58%	803,336 $72 Million
Q3 2020 Nov 16, 2020	BUY	$81.91 - $134.94 $2.89 Million - $4.77 Million	35,341 Added 4.63%	798,696 $82.5 Million
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $16.2 Million - $26.7 Million	-298,319 Reduced 28.1%	763,355 $60.4 Million
Q1 2020 May 14, 2020	BUY	$49.34 - $68.76 $1.34 Million - $1.86 Million	27,082 Added 2.62%	1,061,674 $61.4 Million
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $1.73 Million - $1.99 Million	-33,705 Reduced 3.16%	1,034,592 $55.8 Million
Q3 2019 Nov 13, 2019	BUY	$40.6 - $57.2 $2.72 Million - $3.83 Million	66,878 Added 6.68%	1,068,297 $55.9 Million
Q2 2019 Aug 13, 2019	BUY	$39.92 - $53.86 $3.95 Million - $5.32 Million	98,858 Added 10.95%	1,001,419 $48.4 Million
Q1 2019 May 13, 2019	BUY	$48.23 - $66.16 $1.74 Million - $2.38 Million	35,991 Added 4.15%	902,561 $45.6 Million
Q4 2018 Feb 12, 2019	SELL	$55.63 - $73.24 $5.98 Million - $7.87 Million	-107,466 Reduced 11.03%	866,570 $51.4 Million
Q3 2018 Nov 14, 2018	SELL	$52.05 - $66.51 $9.17 Million - $11.7 Million	-176,148 Reduced 15.31%	974,036 $64.1 Million
Q2 2018 Sep 18, 2018	SELL	$48.33 - $55.64 $150,354 - $173,096	-3,111 Reduced 0.27%	1,150,184 $58.1 Million
Q2 2018 Aug 14, 2018	BUY	$48.33 - $55.64 $5.81 Million - $6.69 Million	120,209 Added 11.64%	1,153,295 $58.2 Million
Q1 2018 May 09, 2018	SELL	$44.44 - $54.39 $28,708 - $35,135	-646 Reduced 0.06%	1,033,086 $54.4 Million
Q4 2017 Feb 14, 2018	SELL	$37.77 - $47.75 $289,053 - $365,430	-7,653 Reduced 0.73%	1,033,732 $48 Million
Q3 2017 Nov 13, 2017	BUY	$34.14 - $40.45 $35.6 Million - $42.1 Million	1,041,385	1,041,385 $42.1 Million

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $442M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Emergent Bio Solutions Inc. Transaction History